103 results
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments … , without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit
8-K
EX-10.4
emj7j6z5lw8u5v 9fns
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.6
zplfwdn5gm8b2w db
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
aupuelc19njf7o3q
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
clf 5zjcy
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
tgaav3jradci9kq36
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
ts10940igrp8g7cp
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
nyx2vxyx5 yj
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
gg1m6vg1sqt
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm